Demand for access to rise in Massachusetts (More from Executive Profile, Dec. 2007)
Increased insurance coverage should boost demand for medical services which would highlight concerns about access to medical care, particularly outside of Boston.
Increased insurance coverage should boost demand for medical services which would highlight concerns about access to medical care, particularly outside of Boston.
"Rural areas tend to have a higher percentage of poor and uninsured and fewer doctors. Insurance alone may not assure access," according to B. Dale Magee, MD, MS, president of the Massachusetts Medical Society.
A shortage of primary care physicians in Massachusetts has led many doctors to stop accepting new patients, according to a recent report by the Massachusetts Medical Society. "Primary care physicians should be central to the delivery of healthcare," Dr. Magee says. "Absent a primary care physician, patients tend to distribute their care among specialists, which can lead to more testing and less continuity and drive up expenses. Distribution of physicians-both within the state and the country-is part of the issue and we need to be cognizant of the fact that physicians have choices in where they can live. Incentives to practice in underserved areas need to be more effective. Some specialties, such as primary care, should be compensated in a manner that recognizes their importance. In that end, the financial consequences of a primary care shortage may cost more than appropriate compensation."
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More
